Phil Sarocco
Head of HEOR-Access US- Biogen
- Role
- Head of Heor-access Us at Biogen
- Location
- Weston, MA, US
- LinkedIn followers
- 500 followers
About Phil Sarocco
Health Economics | Outcomes Research | Market Access/Competitiveness Phil Sarocco p••••••••@gmail.com Building High-Performing Health Economics and Outcomes Research Functions for Competitive Strength As an executive trained in Health Economics and Outcomes Research, I build dynamic home and field-based HE/OR functions that align business strategy with medical research. I blend a clinical pharmacist background with a passion for designing and executing research frameworks that support informed decision-making for drug effectiveness, patient outcomes and market access. Expert collaborator and communicator who works across internal functions and with external medical professionals in prominent global pharma/biotech companies. Translates highly technical/scientific information into accessible language. Contributions: → Transformed pharmaceutical research – Initiated use of real world evidence generation and payer/patient measures of value through all research phases (ValuMax), demonstrating value of Aventis Diabetes therapies for emerging US decision-makers. → Developed Linaclotide global value strategy – Executed successful health technology assessments across major EU markets. Led and presented case for optimal WHO classification. → Key partner in quality of care/payment policy – Generated research showing Brovana as probable Least Costly Alternative in COPD and increased appropriate utilization. Developed and led pay-for-performance pilot for cardiovascular care quality measures. Results drove differential payment for outcomes. → Conceived and led development of Lipid Goal Manager – Instituted patient clinical tracking software in 120+ clinical sites. Improved Lipitor formulary status, access, and use. Key Competencies HE/OR Therapeutic/Brand Strategy HE/OR Infrastructure/Team Building Project Management Analytic Planning Research Design/Implementation/Analysis/Presentation Evidence Generation/Design/Execution Clinical Trials Policy/Regulation
Experience
Head of Heor-access Us
Apr 2021 — Present · Cambridge-Weston, MA
Build out of the Health Economic & Outcomes Research-Access function in Biogen US Medical Affairs. Fully staffed team will consist of 15 professionals-6 US HQ professionals with experience in HEOR methods applied to health plan and payer access of Biogen\'s portfolio of therapies- 9 Field-based, medically credentialed professionals with knowledge and experience with US health plans/payers providing clinical, health economic, and outcomes research data and information to health plans/payers in support access across Biogen\'s portfolio of therapies. HEOR-Access Team leads cross-functional engagement with individual US plans/payers to identify RWE generation study collaboration opportunities.
Education
Harvard School of Public Health
MSc, Management Decision Sciences, Cost Effective/Cost Benefit Analysis, Pharmacoepidemiology, Microeconomics and Risk Analysis
1991 — 1993
Massachusetts College of Pharmacy, Boston MA
BPharm, Licensed RPh
Assumption College, Worcester MA
Chemistry, Biology Minor
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.